Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency
James Verbsky, Mary Hintermeyer, Pippa Simpson, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 2, pp. 704-712.e17
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Immune dysregulation
Andrew M. Long, Anatole Kleiner, R. John Looney
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 1, pp. 70-80
Open Access | Times Cited: 33
There is no gene for CVID — novel monogenetic causes for primary antibody deficiency
Neftali Jose Ramirez, Sara Posadas‐Cantera, Andrés Caballero-Oteyza, et al.
Current Opinion in Immunology (2021) Vol. 72, pp. 176-185
Closed Access | Times Cited: 39
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers
Francesco Cinetto, Riccardo Scarpa, Maria Carrabba, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review
Olivia A. C. Lamers, Bas M. Smits, Helen L. Leavis, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Future of Therapy for Inborn Errors of Immunity
Elena Pérez
Clinical Reviews in Allergy & Immunology (2022) Vol. 63, Iss. 1, pp. 75-89
Open Access | Times Cited: 23
Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives
Børre Fevang
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 627-638
Open Access | Times Cited: 15
Granulomatous inflammation in inborn errors of immunity
Keith Sacco, Andrea Gazzin, Luigi D. Notarangelo, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 14
B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease
Erik M. Matson, Miranda L. Abyazi, Kayla A. Bell, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 28
Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
Mai Sasaki Aanensen Fraz, Annika E. Michelsen, Natasha Moe, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 7, pp. 1553-1563
Open Access | Times Cited: 20
Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review
Heba M Bintalib, Annick van de Ven, Joseph Jacob, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Interstitial Lung Disease Associated with Common Variable Immunodeficiency: Pathogenesis, Diagnostic Challenges, and Therapeutic Strategies
兰 黄
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 508-517
Closed Access
Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients
Giulio Tessarin, Manuela Baronio, Luisa Gazzurelli, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 8, pp. 2091-2103
Open Access | Times Cited: 9
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review
Helena Buso, Claudia Discardi, Patrick Bez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1503-1503
Open Access | Times Cited: 3
Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
Giorgio Costagliola, Rita Consolini
Clinical & Experimental Immunology (2021) Vol. 205, Iss. 3, pp. 288-305
Open Access | Times Cited: 23
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease
Bas M. Smits, Sigune Goldacker, Suranjith L. Seneviratne, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 152, Iss. 2, pp. 528-537
Closed Access | Times Cited: 14
Histology of Interstitial Lung Disease in Common Variable Immune Deficiency
Fatima Dhalla, Dylan J. Mac Lochlainn, Helen Chapel, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 19
Targeted treatments for immune dysregulation in inborn errors of immunity
Nadia Makkoukdji, Valishti Pundit, Matthew Wyke, et al.
Exploration of Immunology (2024), pp. 218-237
Open Access | Times Cited: 2
Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
Jessica Galant-Swafford, Jason Catanzaro, Rosane Duarte Achcar, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102749-102749
Open Access | Times Cited: 2
What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review
Astrid C. van Stigt, Willem A. Dik, Lieke S. Kamphuis, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 16
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency—Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Mai Sasaki Aanensen Fraz, Natasha Moe, Mona‐Elisabeth Revheim, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 14
Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease
Victor Lui, Tusharkanti Ghosh, Amy L. Rymaszewski, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1311-1325
Open Access | Times Cited: 5
Managing Granulomatous–Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey
Annick A. J. M. van de Ven, Tiago M. Alfaro, Alexandra Robinson, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 13
Clinical and experimental treatment of primary humoral immunodeficiencies
Anna Szaflarska, Marzena Lenart, Magdalena Rutkowska-Zapała, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 2, pp. 120-131
Open Access | Times Cited: 1
Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre study
Heba M Bintalib, Sofia Grigoriadou, Smita Y. Patel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency
Astrid C. van Stigt, Giulia Gualtiero, Francesco Cinetto, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 6, pp. 479-487
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top